BRD2 and ovarian cancer: BRD2 mRNA expression exhibited significantly better association with OS among all the ovarian cancer patients together with serous histological subgroup, HR =0.81 (0.71 - 0.92), P=0.0012 (Figure 3A), HR =0.81 (0.69 - 0.96), P=0.012 (Figure 3B).